RIP
NRIX icon

RAM Investment Partners’s Nurix Therapeutics NRIX Stock Holding History

RAM Investment Partners’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$268K Hold
17,284
– – 0.05% 97
2025
Q4 		$328K Hold
17,284
– – 0.06% 78
2025
Q3 		$160K Hold
17,284
– – 0.03% 103
2025
Q2 		$197K Hold
17,284
– – 0.04% 95
2025
Q1 		$205K Hold
17,284
– – 0.05% 88
2024
Q4 		$326K Hold
17,284
– – 0.08% 68
2024
Q3 		$388K Hold
17,284
– – 0.1% 55
2024
Q2 		$361K Buy
+17,284
New +$269K 0.1% 57

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

RAM Investment Partners's NRIX Position: Q1 2026 in Review

RAM Investment Partners held its Nurix Therapeutics (NRIX) position steady in Q1 2026 at 17,284 shares worth $268K. The position accounts for 0.05% of the portfolio, ranked #97.

RAM Investment Partners first reported a position in NRIX in Q2 2024 and has held it in 8 quarters since. The position peaked at $388K in Q3 2024. 195 funds tracked by Wall St. Rank hold NRIX as of Q1 2026.

  • RAM Investment Partners held 17,284 shares of Nurix Therapeutics worth $268K as of Q1 2026.
  • RAM Investment Partners left its Nurix Therapeutics share count unchanged in Q1 2026.
  • Nurix Therapeutics made up 0.05% of RAM Investment Partners's portfolio in Q1 2026, its #97 holding.
  • RAM Investment Partners first reported a position in Nurix Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • RAM Investment Partners's Nurix Therapeutics position peaked at $388K in Q3 2024.
  • 195 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2026.

Based on RAM Investment Partners's 13F filing for Q1 2026, filed 4 May 2026.